# (PART) EMA Methods {-}

# Study Design {#methods}
The starting point of an EMA study should be mindfully planning the general aspects of the study design, as is the case with all scientific research. Issues that need to be considered are, for example, hypotheses and research questions, the target population of interest, recruitment strategies to insure inclusion of a representative study group, comparison groups and allocation strategies (@Shiffman2008). Because ample information on these topics can be found elsewhere (for example X Y Z), this guideline will not address these issues.
When designing an EMA study, researchers also need to carefully consider some specific design aspects. This chapter gives a brief overview the sample plan, power analysis and ethical issues. Outcomes, methods of measurement and data analysis will be discussed seperate chapters. 

## The Sample Plan
One of the main reasons to use EMA is that it can reduce recall bias by measuring during or close to an event, rather than retrospectively. In order to make sure the outcome, pattern and/or context of interest are indeed captured during EMA, a sensible sample plan (or sampling scheme) is required. 

###Active (obtrusive) EMA 

Timing of assessment
Most often EMA sampling focusses on a time-point (signal-contingent plan), an event (event-coningent plan), or a combination of both (@Conner2012b). When a signal-contingent plan is used, a participant receives a prompt and is required to rate an outcome at that moment. A signal plan can either contain fixed or random prompts. For example, in a fixed scheme participants can be prompted to rate their mood every day at 18:00. When prompts are generated randomly, a fixed number of prompts is send at a random time-point within pre-set intervals. For example, a prompt is sent every day between 9:00 and 12:00, 13:00 and 15:00 and 16:00 and 18:00. This latter form of EMA is also described as experience sampling (@Moskowitz2006). Event-contingent sampling requires participants to complete an assessment when a specific event occurs, such as a panic attack or alcohol consumption. In case of coninious monitoring and real-time data processing, it is also possible to trigger event-based prompts automaticaly. For example, by linking a self-report EMA questionnaire to a change in activity level (@Smyth2003). 

Frequency and duration
In order to assure that the outcome of interest is captured, the required number of prompts and duration of assessment need to be considered. The more 



For example, when a researcher is interested in capturing a


burden compliance

match EMA reterospective questionaire 

Battery 

A sample plan contains the following elements: duration (hours, days, weeks, etc.), frequency (every day, hour, minute, etc.), random    

Signal contingent event contingent 

Expected fluctuation/patterns
Duration
Context
Burden
Random or fixed

```{r creating_a_sample_schedule, echo = TRUE}
participants <- 1:5
days <- 1:14
beeps <- 1:10
times = seq(32400, 75600, 300)

sample_schema <- as.data.frame(
  expand.grid(
    id = participants, 
    day = days, 
    beep = beeps))

sample_schema <- sample_schema %>%
  arrange(id, day, beep) %>%
  group_by(id, day) %>%
  mutate(t = sort(sample(times, max(beep)))) %>%
  mutate(t = as.character(hms::as.hms(t)))
```

```{r echo = FALSE}
knitr::kable(
   head(as.data.frame(sample_schema, 10)), 
   booktabs = TRUE,
   caption = 'First 10 rows of the sample schema of participant 1')
```


##  Power Analysis

[How to determine the power of the experiment? Available analytic tools are
too limited (no support for intensive longitudinal schemes. Solution: simulate
data. )] Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam
vehicula augue metus, in tincidunt urna luctus sit amet. Sed ultrices, erat at
laoreet semper, sem tellus hendrerit mi, eget pulvinar massa nisl ac dolor. Nunc
ac tellus nec tortor interdum porta. Vestibulum hendrerit tempus condimentum.
Donec a mollis sem. Aenean lectus nunc, bibendum ut orci vel, tristique
pellentesque arcu. Vestibulum id laoreet neque.

[Simulation tools: rnorm, mvrnorm, Package simstudy] Donec sed lectus at sem
ultrices commodo. Proin a viverra metus, nec scelerisque odio. Morbi viverra
tristique libero vel fringilla. Sed at varius erat, id consequat nibh. Ut eget
leo blandit orci posuere tincidunt ac sed erat. Aenean metus metus, eleifend ut
facilisis a, fringilla ut neque. Nunc hendrerit cursus eleifend. Pellentesque
habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas.
Vivamus enim turpis, pulvinar volutpat purus nec, lobortis imperdiet diam.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam
vehicula augue metus, in tincidunt urna luctus sit amet. Sed ultrices, erat at
laoreet semper, sem tellus hendrerit mi, eget pulvinar massa nisl ac dolor. Nunc
ac tellus nec tortor interdum porta. 

```{r sdsimcor, fig.cap='Cross-correlation of two simulated variables.'}
C <- matrix(c(1.0, 0.2, 
              0.2, 1.0), 
            nrow = 2)

dt <- simstudy::genCorData(1000, 
                           mu = c(4, 12), 
                           sigma = c(1, 2), 
                           corMatrix = C)

with(dt, ccf(V1, V2, ylab = "cross-correlation"))
```


Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam vehicula augue
metus, in tincidunt urna luctus sit amet. Sed ultrices, erat at laoreet semper,
sem tellus hendrerit mi, eget pulvinar massa nisl ac dolor. Nunc ac tellus nec
tortor interdum porta. Vestibulum hendrerit tempus condimentum. Donec a mollis
sem. Aenean lectus nunc, bibendum ut orci vel, tristique pellentesque arcu.
Vestibulum id laoreet neque. Phasellus at ex velit. Vestibulum scelerisque nulla
ut massa tempor, ac dapibus dui viverra.  


## Devices 

Opletten wat je koopt aan technologie Tabel onderbouwen devices 

Gevalideerd vs nieuw

Stabiliteit
Kosten
Back-office
data opslag

What is the data acquisition interface? [@Stone2002] Lorem ipsum dolor sit
amet, consectetur adipiscing elit. Aliquam vehicula augue metus, in tincidunt
urna luctus sit amet. Sed ultrices, erat at laoreet semper, sem tellus hendrerit
mi, eget pulvinar massa nisl ac dolor. Nunc ac tellus nec tortor interdum porta.
Vestibulum hendrerit tempus condimentum. Donec a mollis sem. Aenean lectus nunc,
bibendum ut orci vel, tristique pellentesque arcu. Vestibulum id laoreet neque.
Phasellus at ex velit. Vestibulum scelerisque nulla ut massa tempor, ac dapibus
dui viverra.


## Ethical Considerations

### Medical device

All clinical studies that involve human participants need to be evaluated by a Medical Research and Ethics Committee (MERC, METC in Dutch). Recently, the committees have also been tasked to determine whether a medical device is used and to evaluate the safety and quality of the device. Researchers are therefore required to add a section in the research protocol, explaining why the software/device is or is not a medical device. This chapter gives a brief overview of this process.  

#### Definition of a medical device
The official definition of a medical device (Medical Device Act, or Wet Medische Hulpmiddelen) is as follows (http://www.ccmo.nl/en/research-with-a-medical-device):
“Any instrument, apparatus or appliance, any software or material or any other article that is used alone or in combination, including any accessory and the software required for its proper operation, that is intended by the manufacturer to be used specifically for diagnostic or therapeutic purposes, and is intended by the manufacturer to be used for human beings for the purpose of:
- diagnosis, prevention, monitoring, treatment or alleviation of disease
- diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap
- investigation, replacement or modification of the anatomy or of a physiological process
- control of conception, and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means.”

In short, software can be classified as a medical device if it collects patient-specific data and is specifically intended for one of the above-mentioned objectives. Or in other words, if a health care professional takes this information into account when determining the course of treatment. The law does not differentiate between passive and active measurement.

#### Is my product a medical device?
The website http://cetool.nl/general/scanAid offers a quick scan that helps to determine whether an app of product should be classified as a medical device. Figure XX shows a flow-chart, based on these questions. 

```{r fig.cap = "Flow-chart medical device.", echo = FALSE, out.width = '50%'}
knitr::include_graphics("images/outcomes/Flow_MD.png")
```

#### Grey areas
CASPAR and NESDA studies ivamus enim turpis,
pulvinar volutpat purus nec, lobortis imperdiet diam [not a medical device, only monitording]

#### Classification medical device
Add flowchart? 
Notification of the Health and Youth Care Inspectorate

#### Useful links
Add links to EU and Dutch laws and CCMO website. 

### Data sharing

Intellectueel eigendom
Server
DSA data sharing agreement. 

[EMA data sharing is complicated. Indirect identifiablity should perhaps be the
default assumption. GPS data can not be fully anonymised.] Vivamus enim turpis,
pulvinar volutpat purus nec, lobortis imperdiet diam. Nunc hendrerit cursus
eleifend. Pellentesque habitant morbi tristique senectus et netus et malesuada
fames ac turpis egestas. Vivamus enim turpis, pulvinar volutpat purus nec,
lobortis imperdiet diam.

#### Informed consent
[Informed Consent] Donec sed lectus at sem ultrices commodo. Proin a viverra
metus, nec scelerisque odio. Morbi viverra tristique libero vel fringilla. Sed
at varius erat, id consequat nibh. Ut eget leo blandit orci posuere tincidunt
ac sed erat. Aenean metus metus, eleifend ut facilisis a, fringilla ut neque.
Nunc hendrerit cursus eleifend. Pellentesque habitant morbi tristique senectus
et netus et malesuada fames ac turpis egestas. Vivamus enim turpis, pulvinar
volutpat purus nec, lobortis imperdiet diam.


## Outcomes

Precies def wat meten
betrouwbaarheid, validiteit, ruwe data 

VOlgend hoofdstuk per domein

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam vehicula augue
metus, in tincidunt urna luctus sit amet. Sed ultrices, erat at laoreet semper,
sem tellus hendrerit mi, eget pulvinar massa nisl ac dolor. Nunc ac tellus nec
tortor interdum porta. Vestibulum hendrerit tempus condimentum. Donec a mollis
sem. Aenean lectus nunc, bibendum ut orci vel, tristique pellentesque arcu.
Vestibulum id laoreet neque. Phasellus at ex velit. Vestibulum scelerisque nulla
ut massa tempor, ac dapibus dui viverra.  

Donec sed lectus at sem ultrices commodo. Proin a viverra metus, nec scelerisque
odio. Morbi viverra tristique libero vel fringilla. Sed at varius erat, id
consequat nibh. Ut eget leo blandit orci posuere tincidunt ac sed erat. Aenean
metus metus, eleifend ut facilisis a, fringilla ut neque. Nunc hendrerit
cursus eleifend. Pellentesque habitant morbi tristique senectus et netus et
malesuada fames ac turpis egestas. Vivamus enim turpis, pulvinar volutpat
purus nec, lobortis imperdiet diam.  

